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Abstract Native myoglobin (Mb) consists of two populations
which differ in the orientation of the heme by 180‡ rotation (as
verified by nuclear magnetic resonance) but have identical
absorption spectra and equilibrium^thermodynamic stability.
Here, we report that these two fractions of native oxidized Mb
(from horse) both unfold and refold (chemical denaturant, pH 7,
20‡C) in two parallel kinetic reactions with rate constants
differing 10-fold. In accord, the oxidized heme remains
coordinated to unfolded horse Mb in up to 4 M guanidine
hydrochloride (pH 7, 20‡C).
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Myoglobin (Mb) is one of the most thoroughly studied
proteins with respect to folding, however, most investigations
have been concerned with the apo-form [1^4]. Notably, Bald-
win’s group at Stanford has studied the dynamics of apo-Mb
folding extensively. It has been demonstrated that apo-Mb
unfolds through a compact intermediate upon lowering the
pH [5,6]. This intermediate is also formed rapidly in the ki-
netic process of forming native apo-Mb at pH 6. The unfold-
ing and refolding of the pH 4-stable intermediate (I) has been
probed by stopped-£ow experiments. This intermediate coex-
ists in two distinguishable forms: Ia and Ib. Both are on-path-
way intermediates in the refolding reaction of apo-Mb [7].
The globin fold is made up of eight helices that surround
the heme group in a hydrophobic pocket-like structure; the
heme iron is non-covalently linked to histidine 93. During
protein synthesis, binding of the heme may proceed cotransla-
tionally to the polypeptide still attached to the ribosome [8]. If
this is the case for Mb, the heme group could a¡ect its folding
pathway in vivo. Folding studies of holo-Mb have however
been limited [8,9]. For cyanomet holo-Mb, refolding was
shown to occur by a ¢rst phase with a rate constant of V1
s31 where structure forms around the heme, followed by a
slower ligand exchange process (suggested to be exchange of
CN to the native histidine heme ligand) with a rate constant
of V1033 s31 [8]. In addition, electron transfer-triggered fold-
ing experiments have shown reduced (deoxy) Mb to refold
rapidly (102^103 s31) upon reduction of unfolded, oxidized
(Met) Mb [9].
Nuclear magnetic resonance experiments have revealed that
there are two holo-Mb forms in solution at equilibrium (their
interconversion is extremely slow) which di¡er in the orienta-
tion of the heme by 180‡ rotation about the K-Q-meso axis
[10^12]. The dominant (90% for sperm whale Mb) component
has the same heme orientation as found in the Mb crystal
structure [13]. This non-symmetrical arrangement of heme
orientations in Mb at equilibrium was also probed by visible
circular dichroism (CD) [11]. The amplitude of the positive
CD signal in the Soret region was shown to correlate with the
fraction of dominant heme orientation (as demonstrated for
sperm whale Mb with heme ratio 9:1, and tuna Mb with ratio
3:2). Upon sperm whale Mb reconstitution (adding heme to
folded apo-Mb), there is ¢rst (within ms) an initial 1:1 mix-
ture of holo-Mb with heme in the two orientations, which
then slowly (lifetime of hours to days) rearranges to the equi-
librium 9:1 ratio [10^12]. Thus, at equilibrium, holo-Mb is
heterogeneous albeit Soret absorption and far-UV CD spectra
of the two forms are indistinguishable [12]. We here present
results suggesting that these oxidized (Met) horse Mb popu-
lations (which di¡er in heme orientation) unfold and refold in
two parallel, apparent two-state, reactions with a 10-fold dif-
ference in speed.
2. Materials and methods
Horse Mb was obtained from Sigma (sperm whale Mb was a gift
from H.B. Gray). Gel electrophoresis showed the presence of a minor
component (5^10%) in the horse Mb stock. Therefore, Mb was puri-
¢ed by gel ¢ltration (and checked again by electrophoresis). We found
no di¡erence in folding behavior (equilibrium or kinetics) between the
original stock and the puri¢ed Mb, indicating that our spectroscopic
methods only probe Mb, and the data are not (if using the original
stock) a¡ected by the minor component. Guanidine hydrochloride
(GuHCl) titrations were performed (5 mM phosphate, þ 100 mM
NaCl, pH 7.0, 20‡C) with Met-Mb (5 WM) by following the far-UV
CD signal (OLIS instrument, 200^300 nm), the Soret absorbance
(Cary-50 spectrophotometer, 380^600 nm) and the tryptophan £uo-
rescence (Shimadzu £uorometer, ex 280 nm, 295^450 nm). Kinetic
measurements were made using an Applied Photophysics SX.18MV
stopped-£ow in either £uorescence (ex 280 nm, cut-o¡ ¢lter of
305 nm) or absorption (409 nm) mode. No amplitude changes oc-
curred in the dead time (1.2^1.6 ms) of the instrument. Refolding
was measured by (1:1, 1:5 and 1:10) dilutions of Mb (70 WM) in
2 or 2.5 M GuHCl with appropriate GuHCl/bu¡er solutions to give
desired GuHCl concentrations (20‡C). The averaged kinetic traces
(minimum of eight) were ¢t to bi-exponentials using a non-linear
least-squares algorithm. The kinetic traces could not be ¢t to single
exponentials (except at [GuHCl]s 5 M, where more than 95% of the
amplitude was found in one rate). Absorption and £uorescence-de-
tected kinetics gave identical results, supporting that native Mb was
not contaminated by apo-Mb.
The equilibrium unfolding data (Fig. 1A) were directly ¢t, accord-
ing to a two-state model [14], to yield vGU (unfolding free energy) and
m (degree of hydrophobic exposure upon unfolding). The kinetic un-
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folding and refolding data were ¢t (Fig. 1B) assuming standard linear
dependence of ln kF and ln kU on [GuHCl]:
ln k  lnkFH2OexpmFGuHCl=RT
kUH2OexpmUGuHCl=RT
where mU is the slope of the unfolding branch and mF is the slope of
the folding branch. kF(H2O) and kU(H2O) are the folding and un-
folding rate constants at 0 M GuHCl. The ¢ts were only extended to
4 M GuHCl in the unfolding branch.
3. Results and discussion
Titrations of GuHCl, in 5 mM phosphate pH 7, show that
the equilibrium unfolding of horse Met-Mb is consistent with
a two-state reaction (Fig. 1A). Monitoring the equilibrium
unfolding by far-UV CD, tryptophan £uorescence and Soret
absorption all give identical results (midpoint at 1.5 M); the
unfolding free energy that can be estimated from ¢ts to the
unfolding curves is 21( þ 2) kJ/mol (Table 1). This value is
somewhat lower than earlier such estimates although the mid-
points roughly synchronize [15]. The equilibrium unfolding
transition for horse Met-Mb was not a¡ected by inclusion
of 100 mM NaCl (data not shown). The unfolding of Met-
Mb is fully reversible (up to 5 M GuHCl) and no protein
concentration-dependence was detected for the equilibrium
unfolding transition, suggesting that the heme stays coordi-
nated to the unfolded polypeptide, a conclusion also reached
earlier [9,16]. In further agreement, gel ¢ltration of unfolded
Mb in up to 5 M GuHCl shows the heme to co-elute with the
protein.
To study the kinetics of the Met-Mb folding and unfolding
reactions, we employed stopped-£ow mixing while monitoring
absorption changes at 409 nm or £uorescence changes upon
excitation at 280 nm. The same kinetic results were obtained
independent of the detection method used. The kinetic unfold-
ing data are best ¢t by a sum of two exponentials at each
GuHCl concentration investigated; a faster rate correspond-
ing to 20% of the amplitude change and a slower rate corre-
sponding to 80% of the amplitude change. The logarithms of
both the fast and the slow unfolding rate increase linearly
when the GuHCl concentration is increased (Fig. 1B). In con-
trast, at a GuHCl concentration of 5 M or higher (inset Fig.
1B), the GuHCl-dependence decreases and 100% of the am-
plitude correlates with one fast rate (in 5^6 M GuHCl: rate
constant of approximately 400 s31). This rate constant is sim-
ilar to that determined for heme-His dissociation in unfolded
cytochrome c [17] and, therefore, heme dissociation from His-
93 in Mb is likely to occur under these strongly denaturing
conditions. Gel ¢ltration experiments of unfolded holo-Mb in
6 M GuHCl showed that unfolded polypeptide and heme
eluted as two separate fractions, in support of heme dissoci-
ation at this high denaturant concentration.
The kinetic refolding data for Met-Mb (holo-Mb unfolded
in GuHCl concentrations not dissociating the heme from the
polypeptide) are also best ¢t by a sum of two exponential
phases (Fig. 1B). The slower rate of the two corresponds to
80%, and the faster one to 20%, of the total absorption
change, at all GuHCl concentrations investigated. There is
no di¡erence in refolding rates or amplitude changes when
starting from Mb unfolded in 2.5 M or 2.0 M GuHCl and
there is no protein concentration-dependence (5^35 WM inves-
tigated) in the refolding kinetics. Moreover, kinetic refolding
data (rates and amplitude ratios) detected by tryptophan £uo-
rescence and Soret absorption are identical. When unfolded
Met-Mb is incubated for 1 h or less, we obtain 100% refolding
of holo-protein. Extensive incubation (days), however, of un-
folded Mb (in 2^2.5 M GuHCl) correlates with a decreased
yield of refolded holo-Mb (also reported earlier in [18]). In
contrast, when Mb refolding is initiated from 6 M GuHCl, no
refolded holo-protein at all is detected using stopped-£ow,
again in accord with heme dissociation at very high denatur-
ant concentrations.
Fig. 1. A: Unfolding transition for horse Met-Mb as a function of
GuHCl concentration (pH 7) (solid squares (far-UV CD), solid dia-
monds (tryptophan £uorescence) and open squares (Soret absorp-
tion)). B: Semi-logarithmic plot of horse Met-Mb folding and un-
folding kinetics as a function of [GuHCl]. Open circles, fast rates
(20% of amplitude), and ¢lled circles, slow rates (80% of amplitude).
The Chevron plot exhibits a midpoint around 1.5 M in agreement
with that determined from equilibrium studies (A); each set of data
shows the V-shape indicative of two-state folding. The results from
¢ttings (solid lines) are summarized in Table 1. Inset: unfolding
rates (open circles, fast; ¢lled circles, slow rates) at high GuHCl
concentrations.
FEBS 23458 16-3-00
C. Moczygemba et al./FEBS Letters 470 (2000) 203^206204
The equilibrium ratio of the two heme orientations in native
horse Mb was probed by visible CD. Visible CD of sperm
whale Mb, for which the heme orientation ratio has been
determined earlier to be 9:1, was used as standard [10]. The
signal for horse holo-Mb, at an identical concentration as
sperm whale holo-Mb, has a slightly lower amplitude at
409 nm (9.5 mdeg versus 8.5 mdeg). This signal di¡erence
between horse and sperm whale samples, assuming only the
dominant orientation of heme to contribute to the CD signal
[11], therefore indicates an 8:2 ratio of heme orientations in
native horse Mb (Fig. 2). Since the amplitude ratio for the
unfolding kinetics (8:2) closely matches the equilibrium ratio
of heme orientations (also 8:2) in native Mb, we suggest that
these two populations of folded Mb unfold in two parallel,
separate reactions. In accord, a related b-type heme protein,
bovine cytochrome b5, was also shown to unfold with biphasic
kinetics. As for the Met-Mb unfolding results presented here,
the cytochrome b5 unfolding data were interpreted in terms of
two protein fractions, ascribed to the di¡erent heme conform-
ers in the native state, unfolding in two parallel reactions [19].
It has been shown that the iron^His-93 bond accounts for a
major fraction of the heme-binding energy to folded Mb
[20,21], suggesting that this interaction may prevail also in
unfolded Met-Mb (at least under some conditions). Therefore,
at GuHCl concentrations less than 5 M where no heme dis-
sociation occurs, the heme is likely to remain coordinated to
His-93 upon unfolding and a retention of the two di¡erent
heme orientations is possible in the unfolded state of holo-
Mb. The refolding kinetics (in addition to the unfolding ki-
netics) can thus also be a¡ected by the heme orientation and
may explain the observed biphasic refolding behavior. The
same ratio of fast to slow rates (2:8) is observed in the refold-
ing as in the unfolding experiments. The slow unfolding frac-
tion (designated to Mb with heme in the dominant orienta-
tion) corresponds to the slow refolding fraction; the fast
unfolding and refolding fractions (Mb with heme in the other
orientation) belong together.
The ¢nding of identical ratios of Soret absorption and tryp-
tophan £uorescence amplitude changes for the two rates (both
detection methods yield an amplitude ratio of 8:2 for slow to
fast rates) is consistent with two protein populations unfold-
ing and refolding in parallel. If instead an intermediate had
been involved, the same alteration (relative to folded and un-
folded Mb states) in the two di¡erent spectroscopic probes
would not be expected. Further support for the link between
heme orientation and kinetics emerges from refolding experi-
ments performed after various lengths of incubation of un-
folded holo-Mb samples. If unfolded holo-Mb (in 2.5 M
GuHCl) is incubated for up to 1 h before refolding is initiated,
80% refolds by the slow rate and 20% by the fast rate. Upon
extending this incubation time to 72 h, only 60% refolded in
the slow phase and 40% in the fast. This result suggests that
over time, the heme in unfolded Mb rearranges towards that
of a 1:1 mixture of heme orientations. This is expected, since
no structural constraints are present in the unfolded state (as
is the case in native Mb) and a 1:1 ratio will be energetically
favored. Prolonged incubation of unfolded holo-Mb also al-
lows for some heme dissociation from histidine 93 since the
total yield of refolding was found to decrease somewhat.
In Fig. 1B, the Met-Mb folding and unfolding rates are
combined in a Chevron plot [22^24]. With respect to both
folding and unfolding speed in water, the fast rates are ap-
proximately 10 times higher than the slow rates (Table 1). The
apparent equilibrium stability, estimated from the ratio of the
folding and unfolding rate constants, RTln(kf /ku), in the case
of both the fast and the slow data sets agrees closely with the
value obtained from the equilibrium studies (Table 1). This
observation strongly supports our conclusion of independent
Table 1
Summary of equilibrium and kinetic folding and unfolding data for horse Met-Mb
k(H2O) (s31) vGU (kJ/mol) m (kJ/mol, M)
Equilibrium :
far-UV CD 22.8( þ 2.8) 14.1( þ 1.9)
£uorescence 20.0( þ 3.9) 13.3( þ 2.6)
Soret absorption 22.3( þ 2.4) 13.0( þ 1.4)
Kinetics :
Fast phase (20%) unfolding 0.00011( þ 0.00004) 8.1( þ 0.25)
folding 0.36( þ 0.04) 33.1( þ 0.4)
suma 19.7( þ 1.0) 11.2( þ 0.7)
Slow phase (80%) unfolding 0.000025( þ 0.000007) 8.1( þ 0.21)
folding 0.028( þ 0.003) 33.2( þ 0.4)
suma 17.1( þ 1.0) 11.3( þ 0.6)
avGU =3RT ln(ku/kf ) ; meq = mu3mf .
Fig. 2. CD spectra in the Soret region of horse (solid curve) and
sperm whale (dashed curve) Met-Mb (10 WM protein; 1 cm path-
length). The magnitude of the CD signal at 409 nm re£ects the ratio
of heme in its two possible orientations in the native protein [11].
FEBS 23458 16-3-00
C. Moczygemba et al./FEBS Letters 470 (2000) 203^206 205
two-state unfolding reactions for two Met-Mb populations;
the data are not in agreement with a sequential mechanism
including an intermediate. The relationship meq = mu3mf is
also satis¢ed for each set of data since the value mu3mf
(11.2 for fast and 11.3 kJ/mol,M for slow data) compares
favorably with the equilibrium value (13^14 kJ/mol,M Table
1). The identical ratio (0.3) of kinetic and equilibrium m val-
ues (mf /meq [25] ; reporting on the transition state for folding)
for both the fast and the slow folding holo-Mb populations
indicates that these protein fractions still have very similar
folding pathways.
In summary, our data are consistent (albeit not proven
directly) with the two populations of native Met-Mb, which
di¡er in their orientation of the heme, unfolding and refolding
in parallel reactions. The unfolding and refolding rate con-
stants di¡er by an approximate factor of 10 for the two pro-
tein fractions. This corresponds to an energy di¡erence of
about 6 kJ/mol, ascribed to a di¡erence in transition state
barriers since equilibrium measurements do not distinguish
the two populations. Furthermore, our ¢ndings reported
here emphasize the signi¢cance of speci¢c interactions be-
tween a cofactor and its corresponding unfolded polypeptide
despite the lack of covalent bonds; this has been noted only in
a few other cases [26^29].
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